Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Nurix Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for cancer and inflammatory diseases. Their main products are small molecule and antibody-based drugs, including BTK and CBL-B degraders currently in clinical trials. Nurix has established strategic collaborations with major pharmaceutical companies like Gilead, Sanofi, and Pfizer.
AI-generated summary. Not investment advice.